天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)  antibody-磷酸化蛋白激酶AKT1,2,3抗體,phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)
  • Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)  antibody-磷酸化蛋白激酶AKT1,2,3抗體,phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)
  • Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)  antibody-磷酸化蛋白激酶AKT1,2,3抗體,phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)

Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312) antibody-磷酸化蛋白激酶AKT1,2,3抗體

價(jià)格 1280 1980 2900
包裝 50ul 100ul 200ul
最小起訂量 50ul
發(fā)貨地 上海
文件下載 檢測(cè)報(bào)告COA
更新日期 2024-12-26
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312) antibody-磷酸化蛋白激酶AKT1,2,3抗體英文名稱:phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)
品牌: 滬震生物產(chǎn)地: 中國(guó)/上海
保存條件: -20°C純度規(guī)格: > 99%
產(chǎn)品類別: 抗體 一抗
抗體名: phospho-AKT1/AKT2/AKT3 (Tyr315+Tyr316+Tyr312); AKT1/AKT2/AKT3(phospho-Tyr315/316/312); AKT1/2/3 (phospho Y315 + Y316 + Y312); AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; AKT 2; AKT2; AKT-2; AKT2_HUMAN; AKT 3; AKT3; AKT-3; AKT3_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PKB beta; PKB gamma; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1. 靶點(diǎn): 詳見(jiàn)說(shuō)明書(shū)
宿主: Rabbit適應(yīng)物種: 詳見(jiàn)說(shuō)明書(shū)
克隆性: 詳見(jiàn)說(shuō)明書(shū)濃度: 1mg/ml
應(yīng)用范圍: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.標(biāo)識(shí)物: 詳見(jiàn)說(shuō)明書(shū)
形態(tài): 液體亞型: IgG1
免疫原: 詳見(jiàn)說(shuō)明書(shū)貨號(hào): HZ-R5193
用途范圍: 科研使用規(guī)格: 50ul/100ul/200ul
是否進(jìn)口: 是否單克隆: 詳見(jiàn)說(shuō)明書(shū)
保質(zhì)期: 12個(gè)月抗原來(lái)源: 詳見(jiàn)說(shuō)明書(shū)
標(biāo)記物: 詳見(jiàn)說(shuō)明書(shū)產(chǎn)品用途: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
2024-12-26 Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312) antibody-磷酸化蛋白激酶AKT1,2,3抗體 phospho-AKT1+AKT2+AKT3 (Tyr315+316+312) 50ul/1280RMB;100ul/1980RMB;200ul/2900RMB 1280 滬震生物 中國(guó)/上海 -20°C > 99% 抗體 一抗

Host:Rabbit

Target Protein:phospho-AKT1+AKT2+AKT3 (Tyr315+316+312)

IR:Immunogen Range:PE(p-Y)LA

Clonality:Polyclonal

Isotype:IgG

Entrez Gene:207

Swiss Prot:P31749

Source:KLH conjugated Synthesised phosphopeptide derived from human AKT1 around the phosphorylation site of Tyr315:PE(p-Y)LA 

Purification:affinity purified by Protein A

Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

Background:AKT, also known as protein kinase B (PKB), is a 57 kDa serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold; overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus.

Size:50ul

Concentration:1mg/ml

Applications:WB(1:500-2000)
ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
Flow-Cyt(1μg/Test)
IF(1:100-500)

Cross Reactive Species:Human
Mouse
Rat
Chicken
Dog
Pig
Cow
Rabbit
Sheep

搜狗截圖23年04月28日1343_343.png


本產(chǎn)品僅供科研使用。不能用于人和動(dòng)物治療等其它臨床診斷使用!






關(guān)鍵字: PRKBA;AKT2;AKT 2;AKT-2;AKT 3;

公司簡(jiǎn)介

上海滬震實(shí)業(yè)有限公司是一家集研發(fā)、生產(chǎn)和銷售于一體的生命科學(xué)實(shí)驗(yàn)室產(chǎn)品生物科技企業(yè)。主營(yíng)產(chǎn)品:試劑盒,ELISA試劑盒,抗體,重組蛋白,血清,胎牛血清,細(xì)胞,原代細(xì)胞 細(xì)胞培養(yǎng)試劑,常用生化試劑。
成立日期 2014-05-08 (11年) 注冊(cè)資本 100萬(wàn)元整
員工人數(shù) 10-50人 年?duì)I業(yè)額 ¥ 100萬(wàn)以內(nèi)
主營(yíng)行業(yè) 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) 經(jīng)營(yíng)模式 工廠,試劑,定制,服務(wù)
  • 上海滬震實(shí)業(yè)有限公司
VIP 3年
  • 公司成立:11年
  • 注冊(cè)資本:100萬(wàn)元整
  • 企業(yè)類型:有限責(zé)任公司(國(guó)內(nèi)合資)
  • 主營(yíng)產(chǎn)品:ELISA試劑盒,抗體,細(xì)胞系,原代細(xì)胞,細(xì)胞培養(yǎng)試劑,重組蛋白
  • 公司地址:松江區(qū)
詢盤

Anti-phospho-AKT1+AKT2+AKT3 (Tyr315+316+312) antibody-磷酸化蛋白激酶AKT1,2,3抗體相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
¥1600.00
VIP9年
北京索萊寶科技有限公司
2024-12-26
詢價(jià)
VIP3年
上海嘉定區(qū)澄瀏公路52號(hào)
2024-12-25
詢價(jià)
南京安研生物科技有限公司
2024-05-27
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的